Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Visit the company website

 

Bullboard - Investor Discussion Forum Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s):  VYYRF

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX... see more

TSXV:VM - Post Discussion

Voyageur Pharmaceuticals Ltd > VM is in the Pharma business, not mining
View:
Post by argeliom on Jan 12, 2022 3:40pm

VM is in the Pharma business, not mining

The Willis brothers made a strategic decision to move away from basic mining and enter a specific Pharmaceutical niche where they will enjoy a clear cost competitive advantage plus offer  radiocontrast clients a non China option. They will soon start generating cash flow by start selling by mid 2022 a portion of their product line in Canada using third party sourcing. Long term, they will significanly improve margins by developing their own API minerals source (Francis Creek) and GMP plant scheduled to start production by mid 2023.
I like their understated management process.They had promised the Market their PEA early 2022 and they delivered!! I will bet that the Preliminary Feasibility Report will be delivered before the date promised in the presentation.Also, I am really impressed with the industry consultants supporting VM.
https://voyageurpharmaceuticals.ca/wp-content/uploads/2021/09/Voyageur-Investor-Deck-Oct-2021.pdf
Comment by whitenorth72 on Jan 12, 2022 4:15pm
This is what I understood from their December news release. This is a final document from SRS because all costs and plant design were completed. The plant and processing were part of "phase 2" or feasibility report. Thats what makes this PEA so positive that they can execute and begin financing and building while delivering 3 party products through their Calgary facilities. But maybe I ...more  
Comment by postie1 on Jan 12, 2022 5:03pm
I do believe this is the total cost that you are referring to and this PEA is the base so I take that to mean it is  open for more to be added should the size of the deposit go up. A summary of Mine and Process capital costs are presented in the Table below. Description Capital Mining and On-Site Processing 3.82M Process plant  ...more  
Comment by MineralQuest on Jan 12, 2022 6:48pm
It is mining to the extent that very high purity barite is extracted from near surface deposits. There is also a good likelihood that exploration of the property will result in more being found. Voyaguer differs from most mining in that the barite can be readily made into several pharmaceutical products. There would be no complex milling so the capex is very small. This is a no brainer and I am ...more  
Comment by biggdogg on Jan 13, 2022 12:12pm
Just wait until they repeat the plan on iodine. Once they do, and they will, they will have lowest cost iodine. GE, Bracco, Geurbet, Buyer will be screwed. Iodine using summit nanotech, that is what makes all shareholders serious coin. This is a five year hold for me. I have full confidence.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.VM

follow v.vm on


Voyageur Pharmaceuticals Deck 2024..

The Watchlist

Voyageur Pharmaceuticals | The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

COMPELLING
VALUE PROPOSITION

  • Only pharmaceutical company in the world that owns long-term supply of barium and iodine
  • Natural barium and iodine resources meet increasingly limited global supply and risk
  • Multi-billion-dollar global market for contrast media
  • Poised to obtain significant market share by offering high-quality, lower-cost products
  • Favorable regulatory pathway allows rapid commercialization
  • Highly experienced team has positioned the company for profitable commercial success

Contact Us

Brent Willis, CEO
Brent@Vpharma.ca

Address:
Suite 1600 Dome Tower, 333 7th Avenue S.W.
Calgary, Alberta
T2P 2Z1